Home and Self-Injection of Sayana® Press in Ethiopia: Qualitative Study

This qualitative study investigated the perceptions and policy implications of home and self-injection of Sayana® Press in Ethiopia’s Oromia region. Sayana® Press is the subcutaneous formulation of the three-month injectable depot medroxyprogesterone acetate (DMPA) in the Uniject™ injection system. This study did not include actual product use in humans.

Publication date: May 2013

Available materials

    1. Feasibility of Home and Self-Injection of Sayana® Press in Ethiopia: Results of a Qualitative Study (summary) 236.1 KB PDF

      Hard copies are not available.

    2. Perceptions of Home and Self-Injection of Sayana® Press in Ethiopia: Final Qualitative Study Report 845.1 KB PDF

      Hard copies are not available.